Nuwellis (NUWE)
(Delayed Data from NSDQ)
$1.32 USD
-0.16 (-10.81%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.31 -0.01 (-0.76%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum B VGM
Nuwellis, Inc. (NUWE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$16.00 | $16.00 | $16.00 | 981.08% |
Price Target
Only one analyst offered a short-term price target of $16.00 for Nuwellis, Inc. This represents an increase of 981.08% from the last closing price of $1.48.
Analyst Price Targets (1 )
Broker Rating
Nuwellis, Inc. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, one is Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/29/2024 | Roth Capital Partners | Jonathan Aschoff | Not Available | Strong Buy |
5/3/2024 | Maxim Group | Anthony V Vendetti | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 2 |
Average Target Price | $16.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 61 of 252 |
Current Quarter EPS Est: | -0.88 |
NUWE FAQs
Nuwellis, Inc. (NUWE) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Nuwellis, Inc. (NUWE) is $16.00. The current on short-term price targets is based on 1 reports.
The forecasts for Nuwellis, Inc. (NUWE) range from a low of $16 to a high of $16. The average price target represents a increase of $1112.12 from the last closing price of $1.32.
The current UPSIDE for Nuwellis, Inc. (NUWE) is 1112.12%
Only one analyst offered a short-term price target of $16.00 for Nuwellis, Inc. This represents an increase of 981.08% from the last closing price of $1.48.